Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis

被引：4
作者：
Selvaraj, Shailendra, V [1 ]
Bares, Sara H. [2 ]
Havens, Joshua P. [1 ,2 ]
机构：
[1] Univ Nebraska Med Ctr, Dept Pharm Practice, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Dept Internal Med, Infect Dis, Omaha, NE USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2020年 / 7卷 / 10期
关键词：
emtricitabine/tenofovir alafenamide; pre-exposure prophylaxis; weight gain; DISOPROXIL FUMARATE; DOUBLE-BLIND; TENOFOVIR;
D O I：
10.1093/ofid/ofaa454
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report a case of acute weight gain after switching from emtricitabine/tenofovir disoproxil to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Human Immunodeficiency Virus Pre-Exposure Prophylaxis: Use of Emtricitabine/Tenofovir Alafenamide
    Blackwell, Christopher W.
    Castillo, Humberto Lopez
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2021, 17 (06): : 673 - 676
  • [2] Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection
    Trang, Tracy P.
    Dong, Betty J.
    Kojima, Noah
    Klausner, Jeffrey D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (09) : 1287 - 1294
  • [3] Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue
    Else, Laura
    Penchala, Sujan D.
    Pillay, Azure-Dee
    Seiphetlo, Thabiso B.
    Lebina, Limakatso
    Callebaut, Christian
    Minhas, Suks
    Morley, Roland
    Rashid, Tina
    Martinson, Neil
    Fox, Julie
    Khoo, Saye
    Herrera, Carolina
    PHARMACEUTICS, 2022, 14 (06)
  • [4] Pre-exposure Prophylaxis Against Human Immunodeficiency Virus
    Cinar, Gule
    Birengel, Serhat
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2018, 23 (01): : 1 - 7
  • [5] Preventing New Human Immunodeficiency Virus Infections With Pre-exposure Prophylaxis
    Cotler, Karen
    Yingling, Charles
    Broholm, Cindy
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (05): : 376 - 382
  • [6] Pre-Exposure Prophylaxis as a Method for Prevention of Human Immunodeficiency Virus Infection
    Elbirt, Daniel
    Mahlab-Guri, Keren
    Bezalel-Rosenberg, Shira
    Asher, Ilan
    Sthoeger, Zev
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (05): : 294 - 298
  • [7] The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
    Solomon, Marc M.
    Schechter, Mauro
    Liu, Albert Y.
    McManhan, Vanessa M.
    Guanira, Juan V.
    Hance, Robert J.
    Chariyalertsak, Suwat
    Mayer, Kenneth H.
    Grant, Robert M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (03) : 281 - 286
  • [8] Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins
    Rivera, Adovich S.
    Pak, Katherine J.
    Mefford, Matthew T.
    Hechter, Rulin C.
    JAMA NETWORK OPEN, 2023, 6 (09)
  • [9] Pre-Exposure Prophylaxis for Human Immunodeficiency Virus and Primary Health Care
    RODRIGUES, Bruna
    CUNHA, Maria Joao da
    ACTA MEDICA PORTUGUESA, 2022, 35 (7-8) : 604 - 604
  • [10] Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis
    Gantner, Pierre
    Hessamfar, Mojgan
    Souala, Mohamed Faouzi
    Valin, Nadia
    Simon, Anne
    Ajana, Faiza
    Bouvet, Elisabeth
    Rouveix, Elisabeth
    Cotte, Laurent
    Bani-Sadr, Firouze
    Hustache-Mathieu, Laurent
    Lebrette, Marie-Gisele
    Truchetet, Francois
    Galempoix, Jean-Marie
    Piroth, Lionel
    Pellissier, Gerard
    Muret, Patrice
    Rey, David
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (05) : 943 - 946
12345